{"references": ["1.\tFloyd K., Glaziou Ph., Zumla A., Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. The Lancet. 2018. Vol. 6, P. 299-314.", "2.\thttp://www.who.int/mediacentre/factsheets/fs104/en/", "3.\tKasprowicz V. O., Churchyard G., Lawn S. D., et al. Diagnosing Latent Tuberculosis in High-Risk Individuals: Rising to the Challenge in High-Burden Areas. J Infect Dis. 2011. Vol.204. N. 4. P.1168\u20131178.", "4.\tOn animals protection from cruelty [electronic resource]: Law of Ukraine 21.02.2006 \u2116 3447-IV amended according to Law \u2116 1759-VI (1759-17) 15.12.2009 // Supreme Council of Ukraine. \u2013 2010. \u2013 \u21169. \u2013 76. \u2013 http://zakon.rada.gov.ua/cgi\u2013 bin/laws/main.cgi?nreg=3447\u201315.", "5.\tImmunology Workshop. Cellular, molecular and genetic research methods / ed. L.V. Kovalchuk, G.A.Ignateva, L.V.Gankovskaya - M: Gootar Media, 2010. - 176 p.", "6.\tImmunology: Workshop / E. Pasteur, V.O. Ovod, V.N. Pozur, N.E. Whistle. - K. - Vice school. - Publishing house with Kiev. Un-Those. - 1989. - 304 p."]}

In order to develop dosage forms for the prevention of reactivation of latent tuberculosis, several pharmaceutical compositions were synthesized, from which the most effective activator of phagocytosis completion - succinylformyllysine - was selected. It was found that the use of succinylformillisin increases the functional activity of T-lymphocytes and peritoneal macrophages, normalizes the leukogram of the blood. The most effective composition of diprion and cholecalciferol, capable of inhibiting mycobacterial urease and selective activation of the functional ability of phagocytes and lymphocytes, has also been developed. The aerosol mixture based on these compounds is able to reduce by 37% the number of macrophages with incomplete phagocytosis in the lungs of mice infected with BCG on the background of immunosuppression.